FDA 483 - Davion Inc - May 15, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Davion Inc. in Newark, NJ, a contract manufacturer, was inspected and cited for significant quality system deficiencies. Observations included failures to follow quality control unit procedures, such as inadequate documentation for annual drug product reviews and change control, and not adhering to written cleaning and maintenance procedures for manufacturing equipment. Additionally, the firm lacked proper temperature and humidity monitoring in its warehouse for drug product storage.
- Person
ID · 240cf694-e147-4b80-96b5-b89ae699bc2d